XERS
Xeris Pharmaceuticals Inc
Price:
4.83
USD
Volume:
1,451,792
United States | Pharmaceuticals
XERS Current Ratio
As of 2025-05-25, the Current Ratio of Xeris Biopharma Holdings Inc (XERS) is 1.67.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
XERS Current Ratio - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 1.67 |
| 2023-12-31 | 1.64 |
| 2022-12-31 | 2.54 |
| 2021-12-31 | 1.81 |
| 2020-12-31 | 5.4 |
| 2019-12-31 | 3.21 |
| 2018-12-31 | 11.56 |
| 2017-12-31 | 9 |
| 2016-12-31 | 13.28 |
| - |
XERS Current Ratio - Peers Comparison